These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24853499)

  • 1. Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico.
    Juarez-Molina CI; Valenzuela-Ponce H; Avila-Rios S; Garrido-Rodriguez D; Garcia-Tellez T; Soto-Nava M; Garcia-Morales C; Goulder P; Reyes-Teran G
    AIDS; 2014 Jul; 28(11):1687-90. PubMed ID: 24853499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
    Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
    PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort.
    Olvera A; Ganoza C; Pérez-Álvarez S; Hildebrand W; Sanchez J; Brander C
    AIDS; 2014 Sep; 28(15):2323-5. PubMed ID: 25313587
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada.
    Keynan Y; Becker M; Rueda Z; Bresler K; Kasper K
    Infect Dis (Lond); 2015 Jul; 47(7):447-52. PubMed ID: 25746818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.
    Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P
    J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
    Matthews PC; Koyanagi M; Kløverpris HN; Harndahl M; Stryhn A; Akahoshi T; Gatanaga H; Oka S; Juarez Molina C; Valenzuela Ponce H; Avila Rios S; Cole D; Carlson J; Payne RP; Ogwu A; Bere A; Ndung'u T; Gounder K; Chen F; Riddell L; Luzzi G; Shapiro R; Brander C; Walker B; Sewell AK; Reyes Teran G; Heckerman D; Hunter E; Buus S; Takiguchi M; Goulder PJ
    J Virol; 2012 Dec; 86(23):12643-54. PubMed ID: 22973023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
    Gao X; Nelson GW; Karacki P; Martin MP; Phair J; Kaslow R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; O'Brien SJ; Carrington M
    N Engl J Med; 2001 May; 344(22):1668-75. PubMed ID: 11386265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is low.
    Mori M; Wichukchinda N; Miyahara R; Rojanawiwat A; Pathipvanich P; Maekawa T; Miura T; Goulder P; Yasunami M; Ariyoshi K; Sawanpanyalert P
    AIDS; 2014 Apr; 28(7):959-67. PubMed ID: 24566094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights into the HLA-B35 molecules' classification associated with HIV control.
    Lobos CA; Chatzileontiadou DS; Sok B; Almedia CA; Halim H; D'Orsogna L; Gras S
    Immunol Cell Biol; 2024 Jan; 102(1):34-45. PubMed ID: 37811811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen B distribution in HIV discordant cohort from India.
    Chaudhari DV; Chavan VR; Ahir SP; Kerkar SC; Mehta PR; Mania-Pramanik J
    Immunol Lett; 2013; 156(1-2):1-6. PubMed ID: 24029662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of a novel HLA-B35 (B*3514) allele found in a Mexican family of Nahua Aztec descent.
    Vargas-Alarcon G; Martinez-Laso J; Granados J; Diaz-Campos N; Alvarez M; Gomez-Casado E; Alcocer-Varela J; Arnaiz-Villena A
    Hum Immunol; 1996 Feb; 45(2):148-51. PubMed ID: 8882414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic heterogeneity of HLA-B35 subtypes in different populations as assessed by DNA typing.
    Satz ML; Fernández-Viña M; Theiler GC; Marcos YC; Lindel N; Capucchio M; Gorodezky C; Fainboim L; Stastny P
    Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):196-203. PubMed ID: 8525479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 progression links with viral genetic variability and subtype, and patient's HLA type: analysis of a Nairobi-Kenyan cohort.
    Abidi SH; Shahid A; Lakhani LS; Shah R; Okinda N; Ojwang P; Abbas F; Rowland-Jones S; Ali S
    Med Microbiol Immunol; 2014 Feb; 203(1):57-63. PubMed ID: 24142198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of human leukocyte antigen-types on disease progression among HIV-2 infected patients in Guinea-Bissau.
    Thomsen D; Erikstrup C; Jespersen S; Medina C; Té DDS; Correira FG; Christiansen M; Wejse C; Krarup H; Møller BK; Hønge BL;
    AIDS; 2018 Mar; 32(6):721-728. PubMed ID: 29369163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control.
    Murakoshi H; Koyanagi M; Akahoshi T; Chikata T; Kuse N; Gatanaga H; Rowland-Jones SL; Oka S; Takiguchi M
    EBioMedicine; 2018 Oct; 36():103-112. PubMed ID: 30249546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between MHC class I and susceptibility to HIV-2 disease progression.
    Diouf K; Sarr AD; Eisen G; Popper S; Mboup S; Kanki P
    J Hum Virol; 2002; 5(1):1-7. PubMed ID: 12352262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection.
    Itescu S; Rose S; Dwyer E; Winchester R
    Hum Immunol; 1995 Jan; 42(1):81-9. PubMed ID: 7751163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of vertical HIV transmission combines the 'B35-Cw4 disadvantage' and the 'pattern of inheritance' theories of progression.
    Arnaiz-Villena A; Martín-Villa JM; Amador JT; Cendoya-Matamoros A; Tomé MI; Rivera JM; Martinez-Quiles N
    Curr HIV Res; 2009 May; 7(3):314-9. PubMed ID: 19442128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.